Source: MedGen UID: 262817⇩ Severe acute respiratory syndrome
A viral disorder characterized by high FEVER,
dry COUGH, shortness of breath (DYSPNEA) or
breathing difficulties, and ATYPICAL PNEUMONIA.
A virus in the genus CORONAVIRUS is the
Antiserum productMiddle East respiratory syndromeSARS Coronavirus Protease PathwaySusceptibility to coronavirus 229eViral BreakthroughViral DiseaseViral Fusion Protein InhibitorsViral LoadViral Lower Respiratory InfectionViral PathogenesisViral PneumoniaViral Respiratory Tract InfectionViral Upper Respiratory Tract InfectionViral VaccineViral VectorViremia
PRJNA244298 Cytokine stimulation systems
approach demonstrates differences in innate
and pro-inflammatory host responses between
genetically distinct MERS-CoV isolates.
PRJNA118845 Dynamic Innate Immune
Responses of Human Bronchial Epithelial Cells
against SARS-CoV and DOHV infection
PRJNA97445 Gene expression profiling of
patients with severe acute respiratory
32130047 Déjà Vu or Jamais Vu? How the Severe
Acute Respiratory Syndrome Experience
Influenced a Singapore Radiology Department's
Response to the Coronavirus Disease
32130038Coronavirus Disease 2019
(COVID-19): Role of Chest CT in Diagnosis and
32128276 Long-term bone and lung
consequences associated with
hospital-acquired severe acute
respiratory syndrome: a 15-year
follow-up from a prospective cohort study.
32125362 Epidemiologic Features and
Clinical Course of Patients Infected With
SARS-CoV-2 in Singapore.
32124990 Analyzing the Epidemiological
Outbreak of COVID-19: A Visual Exploratory
Data Analysis (EDA) Approach.
32117225 Novel Insights Into Immune Systems
32116147Coronavirus disinfection in
32115733Coronavirusdisease (COVID-19) and
neonate: What neonatologist need to know.
32115732 The Wuhan SARS-CoV-2 -
What's Next for China.
32112977World Health Organization declares
Global Emergency: A review of the 2019 Novel
32111449 2019 novel coronavirus disease
(COVID-19) in Taiwan: Reports of two cases
from Wuhan, China.
32111262 A mathematical model for simulating
the phase-based transmissibility of a novel
32110875 Potential Rapid Diagnostics, Vaccine
and Therapeutics for 2019 Novel Coronavirus
(2019-nCoV): A Systematic Review.
32109254 A Bayesian approach for detecting a
disease that is not being modeled.
32108862 Genome Detective Coronavirus
Typing Tool for rapid identification and
characterization of novel coronavirus genomes.
32108495 Radiology Perspective of
Coronavirus Disease 2019 (COVID-19):
Severe Acute Respiratory Syndrome and
Middle East Respiratory Syndrome.
32108351 Clinical characteristics of 50466
hospitalized patients with 2019-nCoV infection.
32107119Coronavirus Disease 2019:
Coronaviruses and Blood Safety.
32106567 Preliminary Identification of Potential
Vaccine Targets for the COVID-19 Coronavirus
(SARS-CoV-2) Based on SARS-CoV
32105680Coronavirus Disease 2019
(COVID-19) and Pregnancy: What obstetricians
need to know.
32105637 Radiological findings from 81
patients with COVID-19 pneumonia in Wuhan,
China: a descriptive study.
32104915 The neuroinvasive potential of
SARS-CoV2 may be at least partially
responsible for the respiratory failure of
32098422 Systematic Comparison of Two
Animal-to-Human Transmitted Human
Coronaviruses: SARS-CoV-2 and SARS-CoV.
32096611 2019 novel coronavirus infection and
32094225 The antiviral compound remdesivir
potently inhibits RNA-dependent RNA
Middle East respiratory syndromecoronavirus.
32093211 Characteristics of and Public Health
Responses to the Coronavirus Disease 2019
Outbreak in China.
32092911Rigidity of the Outer Shell Predicted
by a Protein Intrinsic Disorder Model Sheds
Light on the COVID-19 (Wuhan-2019-nCoV)
32091134 Facing the COVID-19 outbreak:
What should we know and what could we do?
32086938 The SARS, MERS and novel
coronavirus (COVID-19) epidemics, the newest
and biggest global health threats: what lessons
have we learned?
32083985Coronavirus Disease 2019
(COVID-19): A Perspective from China.
32083638 Processing of the SARS-CoV
pp1a/ab nsp7-10 region.
32081636Severe acute respiratory syndromecoronavirus 2 (SARS-CoV-2) and coronavirus
disease-2019 (COVID-19): The epidemic and
32080991Viral Load Kinetics of SARS-CoV-2
Infection in First Two Patients in Korea.
32077115 Clinical characteristics of 140
patients infected with SARS-CoV-2 in Wuhan,
32073161 The course of clinical diagnosis and
treatment of a case infected with
coronavirus disease 2019.
32070465 First cases of coronavirus disease
2019 (COVID-19) in France: surveillance,
investigations and control measures, January
32065348 Can Chinese Medicine Be Used for
Prevention of Corona Virus Disease 2019
(COVID-19)? A Review of Historical Classics,
Research Evidence and Current Prevention
32062645 Challenges to the system of reserve
medical supplies for public health emergencies:
reflections on the outbreak of the
severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) epidemic in China.
32056249 Overlapping and discrete aspects of
the pathology and pathogenesis of the
emerging human pathogenic coronaviruses
SARS-CoV, MERS-CoV, and 2019-nCoV.
32056235 Does SARS-CoV-2 has a longer
incubation period than SARS and MERS?
32054787 Prophylactic and therapeutic
remdesivir (GS-5734) treatment in the rhesus
macaque model of MERS-CoV infection.
32052918 The 2019 Coronavirus: Learning
Curves, Lessons, and the Weakest Link.
32052373 Practical recommendations for
critical care and anesthesiology teams caring
for novel coronavirus (2019-nCoV) patients.
32050635 Potential Maternal and Infant
Outcomes from (Wuhan) Coronavirus
2019-nCoV Infecting Pregnant Women:
Lessons from SARS, MERS, and Other Human
32048815 Preliminary prediction of the basic
reproduction number of the Wuhan novel
32040667 Critical care management of adults
with community-acquired severe respiratory
32040506 Host factor prioritization for pan-viral
genetic perturbation screens using random
intercept models and network propagation.
32037447 Griffithsin Inhibits Nipah Virus Entry
and Fusion and Can Protect Syrian Golden
Hamsters From Lethal Nipah Virus Challenge.
32036774 Emerging novel Coronavirus
(2019-nCoV) - Current scenario, evolutionary
perspective based on genome analysis and
32035997 Persistence of coronaviruses on
inanimate surfaces and their inactivation with
32035028 Genome Composition and
Divergence of the Novel Coronavirus
(2019-nCoV) Originating in China.
32031668 An integrative review of the limited
evidence on international travel bans as an
emerging infectious disease disaster control
32027036 Genomic variance of the 2019-nCoV
32024089 Estimating the Unreported Number
of Novel Coronavirus (2019-nCoV) Cases in
China in the First Half of January 2020: A
Data-Driven Modelling Analysis of the Early
32019669 Pattern of early human-to-human
transmission of Wuhan 2019 novel coronavirus
(2019-nCoV), December 2019 to January
32007145 Genomic characterisation and
epidemiology of 2019 novel coronavirus:
implications for virus origins and
32006468 Recent discovery and development
of inhibitors targeting coronaviruses.
31244113 Design, Synthesis, and Anti-RNA
Virus Activity of 6'-Fluorinated-Aristeromycin
31231549 SARS-Coronavirus Open Reading
Frame-8b triggers intracellular stress pathways
and activates NLRP3 inflammasomes.
31226023 Human Coronavirus: Host-Pathogen
31199522 Severe acute respiratory syndrome
coronavirus spike protein counteracts
BST2-mediated restriction of virus-like particle
31191192 History and Future of Nucleic Acid
Amplification Technology Blood Donor Testing.
31133031 Coronavirus envelope protein:
31131400 Delicate structural coordination of
the Severe Acute Respiratory Syndrome
coronavirus Nsp13 upon ATP hydrolysis.
31076983 Complete genome analysis of a
SARS-like bat coronavirus identified in the
Republic of Korea.
31054790 Emerging respiratory infections: The
infectious disease pathology of SARS, MERS,
pandemic influenza, and Legionella.
31034780 Severe acute respiratory syndrome
coronavirus ORF3a protein activates the
NLRP3 inflammasome by promoting
TRAF3-dependent ubiquitination of ASC.
31013648 Factors Influencing the Response to
Infectious Diseases: Focusing on the Case of
SARS and MERS in South Korea.
31007619 An overview of the National
Microbiology Laboratory emergency
31007618 Fifteen years post-SARS: Key
milestones in Canada's public health
30993689 Vaccines for emerging pathogens:
from research to the clinic.
30985968 Emerging respiratory infections
threatening public health in the Asia-Pacific
region: A position paper of the Asian Pacific
Society of Respirology.
30984169 Infectious Disease Threats in the
Twenty-First Century: Strengthening the Global
30943371 SARS coronavirus protein nsp1
disrupts localization of Nup93 from the nuclear
30925168 Bayesian inference of transmission
chains using timing of symptoms, pathogen
genomes and contact data.
30918074 High-throughput Screening and
Identification of Potent Broad-spectrum
Inhibitors of Coronaviruses.
30891557 The battle against SARS and MERS
coronaviruses: Reservoirs and Animal Models.
28659436 Broad-spectrum antiviral GS-5734
inhibits both epidemic and zoonotic
21325420 Evidence that TMPRSS2 activates the
severe acute respiratory syndrome coronavirus
spike protein for membrane fusion and reduces
viral control by the humoral immune response.
16912115Severe acute respiratory syndromecoronavirus nsp1 protein suppresses host gene
expression by promoting host mRNA degradation.
15655079 Expression profile of immune response
genes in patients with Severe Acute Respiratory
3443102 Long-term Assessment of Organ
Functions Among Survivors of Severe Acute
3274544 Clinical Trial of Chinese Herbal
Medicine for Idiopathic Pulmonary Fibrosis (IPF)
2738645 A Clinical Cohort Study of Pneumonia
in Respiratory Intensive Care Unit
2670187 Phase I, Open Label Dose Ranging
Safety Study of GLS-5300 in Healthy
2338986 Collection of Plasma From People
Who Recovered From or Were Vaccinated to
Emerging Infectious Diseases
1979705 Detect Novel Pathogens and
Characterize Emerging Infections
1376765 Phase I Dose Escalation SARS-CoV
Recombinant S Protein, With and Without
Adjuvant, Vaccine Study
1302418 Collection and Testing of Respiratory
1200953 Admission and Management of
Occupational or Other Exposures to
Biodefense/Bioterrorism Agents or to
Epidemic/Emerging Infectious Diseases
578825 A Multi-centre, Double-blinded,
Randomized, Placebo-controlled Trial on the
Efficacy and Safety of Lopinavir / Ritonavir Plus
Ribavirin in the Treatment of Severe Acute
533741 SARS Coronavirus Vaccine
523276 SARS Survivor Evaluations
342524 Collection of Convalescent SARS
Plasma by Apheresis
215826 Study of Alferon® LDO (Low Dose Oral)
in Normal Volunteers
173576 Clinical Study of SARS in Children
173563 Induction of Cytokines in Human
Monocytes by SARS-CoV in Adults and
173459 Dynamic Profiles of
Cytokine/Chemokine in Severe Acute
173017 The Physiological Impact of N95
Masks on Medical Staff
172263 The Interaction Between Severe Acute
Respiratory Distress Syndrome Viral Proteins
150475 Contamination During Removal of Two
Different Personal Protective Systems